CYP1A2 and Parkinson disease: CAF interacts with specific genetic variants such as MAPT, SLC2A13, LRRK2, ApoE, NOS2A, GRIN2A, CYP1A2, and ADORA2A, which may influence the risk of developing Parkinson’s Disease (PD).